Hope. Now within reach. Aiming to reach a billion patients worldwide with affordable, lifesaving medicines.
Let’s fight the COVID-19 outbreak DCGI gives NOD for Restricted Emergency Use of Itolizumab in Moderate to Severe COVID-19 Patients.
Meeting unmet patient needs Our novel biologics address unmet medical needs across the world.
Research saves lives We are accelerating drug innovation and development for companies globally.
The 10-cent answer to diabetes At 10 cents a day, our insulin is a game changer in the developing world.
Abhijit Zutshi, our Global Commercial Head – Generic Formulations, highlights his experience and the process of setting up an affiliate in the US.
Renuka Ganesh, our Human Resources lead, based in Bengaluru, highlights the Biocon culture, that is primarily based on innovation.
Bhamidipati S.V. Prasad, oversees our Small Molecules Business at our Bengaluru site. He explains how Biocon provides opportunities in diversified technologies.
Ankur Bhatnagar, our General Manager for Science and Technology Innovation, talks about how he and his team overcome challenges in designing production processes.
Pooja Hurkat’s struggle with TYPE 1 diabetes
Meet Mrs Kumudha Raju just one of the many women fighting HER2-Positive breast cancer
Neelam’s fight against ascites and ovarian cancer
eLAJ SMart Clinics diagnose NCDs early and improve health care.
Biocon’s outreach program helps fight oral cancer
Biocon Academy: Bridging the Gap between Academia and Biotech Industry
Know more about us
>> Biocon Biologics >> Syngene >> Bicara